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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S366actual in vivo level. Dynamic axial torque with corresponding cyclic
axial load (35% BW) results in a feasible representation of physiological
tibio-femoral kinematics and contact pressures. Although in develop-
ment, the bio-mechano-reactor provides a completely novel tool to
study cartilage damage and repair in OA.Figure 1. A Bioreactor assembled in biomechanics reproducing setup B
Representation of bioreactor for whole joint culturing C Intra-articular
contact pressure measurementTable 1
PG turnover (meanSD) after preparation and after whole joint culture
A PG synthesis (nmol/h/gr) p<
Joint isolation
Experimental (n ¼ 3) 4.60.8
p ¼ 0.74
Control (n ¼ 3) 4.50.7
B
Whole joint culture:
Experimental (average) 2.91.3
Medium contact 4.61.1
Non-medium contact 1.30.6
p ¼ 0.001
Control (average) 15.32.1
Medium contact 18.52.6 p¼0.001
Non-medium contact 12.01.5 p¼0.001
Table 1
Differences* of T2 relaxation time and WORMS grades by level of physical activity (N ¼
Insufﬁcient – Inactive
T2 Difference* CI (95%)y
Lateral femoral 0.39 (0.26–1.05)
Lateral tibia 0.41 (0.33–1.15)
Medial femoral 0.78 (0.32–1.89)
Medial tibia 0.35 (0.31–1.00)
Patella 0.53 (1,56–0.46)
Average of all compartments 0.14 (0.40–0.68)
Cartilage
WORMS max 0.16 (0.34–0.65)
WORMS sum 0.71 (2.03-0.61)
WORMS sum compartment 0.19 (0.51–0.13)
Meniscus
WORMS max 0.34 (0.03–0.71)
WORMS sum 0.86 (0.15–1.87)
WORMS sum compartment 0.32 (0.02-0.62)
No. of lesions Medial Meniscus 0.37 (0.13–0.87)
No. of lesions Lateral Meniscus 0.20 (0.09–0.51)
BMEP
WORMS max 0.32 (0.01–0.63)
WORMS sum 0.39 (0.39–1.18)
WORMS sum compartment 0.20 (0.07–0.48)
*Differences from least square means, adjusted for age, sex BMI contralateral knee pain an
highest score in any sub compartment. WORMS sum score ¼ sum of individual subcomp
lesions. Bold numbers are statistically signiﬁcant (P < 0.05)643
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Objective: The purpose of our study was to assess the cross-sectional
association between physical activity levels, measured objectively by
accelerometers, and structural knee abnormalities as well as cartilage
T2 relaxation times assessed with 3 Tesla MRI in asymptomatic subjects.
Methods: The study sample consisted of 217 subjects from the OAI
(http://www.oai.ucsf.edu) who met our inclusion criteria and had
accelerometer data at the 48month clinic visit. Inclusion criteria for this
study were: at baseline an age < 70 years, Kellgren-Lawrence (K/L)
score  1 in the right knee and  2 in the left knee, and at 48 months
Western Ontario and McMaster Universities Osteoarthritis Index
(WOMAC) pain score  1 in both knees and the subject reported that
they did not limit or modify their activities due to knee pain in the past
2 years. MR images of the right knee, obtained using 3.0 Tesla scanners,
were assessed for structural knee abnormalities using a modiﬁed
Whole-Organ Magnetic Resonance Score (WORMS) and for T2-relaxa-
tion times that were calculated from segmented cartilage of the medial
and lateral compartment of the femur and tibia as well as from thePG release (%) p< PG content (mg/gr) p<
13.51.4 25.21.6
p ¼ 0.16 p ¼ 0.39
17.91.9 23.60.3
18.71.4 23.91.6
p ¼ 0.51 p ¼ 0.12
22.24.1 20.21.3
217 right knees)
Recommended – Inactive
P Difference* CI (95%)y P
0.234 0.36 (0.45–1.19) 0.383
0.271 -0.24 (0.68–1.17) 0.597
0.163 0.81 (0.46–2.07) 0.208
0.297 0.79 (0.03–1.62) 0.059
0.291 -0.12 (1.37–1.12) 0.848
0.609 0.37 (0.30–1.05) 0.275
0.531 0.29 (0.33–0.92) 0.35
0.294 -0.22 (1.88-1.44) 0.79
0.241 -0.03 (0.44–0.37) 0.882
0.076 0.41 (0.05–0.88) 0.082
0.022 0.86 (0.15–1.87) 0.061
0.036 0.40 (0.03-0.78) 0.034
0.145 0.92 (0.29–1.55) 0.004
0,192 -0.12 (0.51–0.25) 0.51
0.040 0.52 (0.13–0.91) 0.008
0.326 0.63 (0.35–1.62) 0.205
0.154 0.21 (0.13–0.56) 0.214
d family history for knee replacement. y Conﬁdence interval of 95 %. WORMSmax ¼
artment. WORMS sum compartment ¼ number of subcompartments with positive
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over a time period of 7 days with an ActiGraph GT1M accelerometer.
Physical activity levels were deﬁned based on the 2008 Physical Activity
Guidelines for Americans (PAGA): Recommended (150 minutes of
moderate/vigorous [MV] activity per week acquired in bouts 10
minutes), Low (1 MV activity bout[s] per week but below guideline),
or Inactive (zero MV activity bouts per week. Linear regression analysis
was used to evaluate differences in WORMS grades and T2 measure-
ments between physical activity levels. Covariates included age, sex,
BMI, contralateral knee pain and family history for knee replacement.
Results: In asymptomatic subjects without radiographic OA in the study
knee at baseline, no associations were found between physical activity
levels and focal cartilage lesions or T2 levels in any compartment.
However, subjects who met the PAGA recommendations had an
increased meniscal lesion score predominantly on the medial side (No.
of lesions in medial meniscus P ¼ 0.004) and an increased BMEP lesion
score (WORMS maximum score, P ¼ 0.008) compared to inactive sub-
jects (Table 1). In exploratory analyses of subjects with a BMI <27,
signiﬁcant increases in cartilage T2 relaxation time were found in the
lateral femoral cartilage (mean increase: 1.02; 95% CI: 0.01-2.03;
p¼0.047), the medial tibial cartilage (mean increase: 1.40; 95% CI: 0.38 -
2.44; p¼0.007) and in the average of all compartments (mean increase:
0.90; 95% CI: 0.04 - 1.76; p¼0.038) in subjects with recommended
physical activity levels compared to inactive subjects.
Conclusion: We found that in knees without radiographic OA in
asymptomatic subjects, recommended levels of physical activity were
associated with increases in meniscal and BMEP lesions compared to
inactive subjects. In normal weight subjects, higher activity levels may
be associated with early evidence of cartilage degradation. The impli-
cations of these ﬁndings for long term health of the knee in active
individual remains to be determined.
644
THE ROLE OF SITE-1 PROTEASE IN THE PATHOGENESIS OF
OSTEOARTHRITIS
K. Tao, Sr. y, H.J. Lin, Sr. y, H. Zeng, Sr. z. y Peking Univ. People’s Hosp.,
Beijing, China; zDept. of Orthopaedics of Peking Univ. Shenzhen Hosp.,
Shenzhen, China
Objective: Previous researches have elaborated that osteoarthritis (OA)
is a metabolic disease with the epigenetic and proteomic analysis
studies for various lipid metabolism-related genes and proteins com-
paring osteoarthritic cartilage with normal. Site-1 protease (S1P) or
subtilisin/kexin-isoenzyme-1 (SKI-1) is a membrane-bound pyrolysin-
like serine protease, regulating cholesterol and fatty acids pathways by
cleaving Sterol Regulatory Element Binding Proteins (SREBPs), andmost
recently several experimental studies have provided evidence that S1P
is essential for endochondral bone formation and involving in chon-
drocyte function. However, there has been no report so far on the
relationship between site-1 protease (S1P) with OA. Thus, we con-
centrated on the role and possible mechanism of S1P in the patho-
genesis of osteoarthritis.
Material and methods: Cartilage tissues were obtained from total knee
arthroplasty for osteoarthritis or total hip arthroplasty for fracture of
neck of femur (normal control group). Meanwhile, the normal and
osteoarthritic cartilage isolated from of C57BL/6 mice and spontaneous
osteoarthritic littermates. Then, immunohistochemical staining and
ﬂuorescence quantitative polymerase chain reaction (FQ-PCR) were
performed to detect the expression of S1P, SREBP-2, 3-hydroxy-3-
methyl-glutaryl-CoA reductase (HMG-CoAR), SOX9, type II collagen and
aggrecan. Furthermore, we treated normal chondrocytes with inter-
leukin-1 beta (IL-1b), and evaluated the expression of the above genes
and monocyte chemotactic protein-1 (MCP-1).
Results: we found that the expression of S1P, SREBP-2, HMG-CoAR,
SOX9, type II collagen and aggrecan in OA patients and normal controls
were signiﬁcantly different, and similar results obtained in the two
C57BL/6 mice groups. After induced by IL-1b, normal chondrocytes
became hypertrophy-like chondrocytes, and notably, the expression of
S1P, SREBP-2, metalloproteinase-1 (MMP-1), metalloproteinase-13
(MMP-13), MCP-1 and HMG-CoAR were upregulated, and SOX9, type II
collagen and aggrecan were inhibited in vitro.Conclusion: These data suggest that provided evidence on the associ-
ation of S1Pwith OA pathogenesis. Proinﬂammatory cytokine IL-1bmay
inﬂuence the hypertrophy and function of chondrocyte through S1P.
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Purpose: The gold standard for assessing joint damage of osteoarthritis
(OA) is still the plain radiograph. However, this method only provides a
historical view of the skeletal damage that has already occurred. Radi-
ography is relatively insensitive, and does not allow for the early detec-
tion of in joint tissues and early joint damage. In joint diseases, there is a
loss of the normal balance between the synthesis and degradation of the
molecules that provide the articular cartilage with its biochemical and
functional properties. Biomarkers are candidates that are now being used
to detect and monitor cartilage metabolism for critical assessment of the
pathophysiological processes that lead to joint failure in OA patients.
Currently, many kinds of biochemical markers associated with the car-
tilage metabolism have been investigated. Pro-collagen type II C-pro-
peptide (PIICP) is a c-terminal peptide produced in the course of
synthesis of type II collagen and can be assayed in synovial ﬂuid and
serum by a speciﬁc immunoassay (ELISA). It was previously reported that
both synovial ﬂuid and serum levels of PIICP were increased in the
subjects with doubtful knee OA (Kellgren & Lawrence grading [K/L] grade
0-1). We have also reported that, in contrast to the increase in the urinary
levels of cartilage degradation biomarker, C-terminal telopeptides of type
II collagen (CTX-II), the serum levels of CPII, which is one of the other
cartilage synthesis biomarkers, were decreased in patients with early
stage of knee OA (K/L grade 2), where the radiographic joint space nar-
rowing became clear. Based on these results, we hypothesized that the
lower cartilage synthesis was associated with the reduction of articular
cartilage thickness of the knee joint.
The purpose of this study is to investigate the hypothesis by evaluating
whether there is an association between serum levels of PIICP and the
radiographic joint space narrowing of the knee joints.
Methods: Fourty seven healthy men volunteers (41.0 y in average) were
enrolled in this study. They didn’t have any symptoms for knee pain and
experience any traumatic episodes for the knee joints. In addition to the
basal characteristics of the subjects, a standing, extended antero-pos-
terior view radiograph of both knee and serum levels of PIICP were also
measured at the time of study entry. Serum levels of PIICP were
measured by ELISA (Uscn life science: SEA964Hu PIICP). Experienced
readers read the radiographs independently recorded the radiographic
features of K/L grade and joint space width (JSW). JSW was determined
at the center point of the medial femoro-tibial compartment on a
radiograph using a 0.1-mm graduated magnifying lens. For each par-
ticipant, the higher K/L grade and the lower JSW of the ﬁndings of both
knees used for the analysis as targeted knee. The statistical analyses
were conducted using the SPSS (SPSS version 17.0). Relationships
between JSWand serum levels of PIICP were assessed bymultiple linear
regression analysis with adjustments for age and body mass index
(BMI).
Results: Of 47 subjects, 17 showed a K/L grade 0, 24 showed a K/L grade
1 and 6 showed a K/L grade 2 on radiographs. The serum levels of PIICP
was 261.6 pg/mL on average (SD; 81.6 pg/mL), and the JSW in the tar-
geted knee was 4.52 mm on average (SD; 0.94). No signiﬁcant differ-
ences of the serum levels of PIICP were observed between the groups
divided by the severity of K/L grade (p¼0.352). Multiple linear regres-
sion analysis with adjustments for age and BMI showed signiﬁcant
positive correlations between the radiographs JSW and the serum PIICP
level (b¼0.404, p ¼ 0.007).
